Stockreport

Clementia Granted Rare Pediatric Disease Designation by FDA for Palovarotene for Fibrodysplasia Ossificans Progressiva [Canadian Business Journal (Canada)]

CLEMENTIA PHARMACEUTICALS INC COMMON SHARES  (CMTA) 
Last clementia pharmaceuticals inc common shares earnings: 11/7 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.clementiapharma.com/investor-relations
PDF Clementia Granted Rare Pediatric Disease Designation by FDA for Palovarotene for Fibrodysplasia Ossificans Progressiva, The Canadian Business Journal makers MONTREAL, Fe [Read more]